You searched for non small cell lung cancer
Your search for non small cell lung cancer returned 493 results
Drug News
For developed countries, there are wide disparities in stage-specific survival for patients with non-small-cell lung cancer , some of which can be explained by stage at diagnosis.
News
An updated index incorporating gene and molecular alterations can predict survival in non-small-cell lung cancer (NSCLC) with brain metastases.
Drug News
Postoperative radiation therapy (PORT) is not associated with improved survival for elderly patients with N2 non-small-cell lung cancer (NSCLC).
Drugs in the Pipeline
The sBLA is supported by data from the phase 2 DESTINY-Lung01 trial, along with a phase 1 trial published in Cancer Discovery.
Drug News
A new study has identified significant differences between non-small-cell lung cancer patients who smoke and those who don't.
News
Vandetanib does not improve overall survival for patients who have received previous treatment for advanced non-small-cell lung cancer (NSCLC).
News
The Food and Drug Administration has granted accelerated approval to Tabrecta™ (capmatinib; Novartis).
News
The approval of Imfinzi is based on the positive PFS data from the Phase 3 PACIFIC trial.
Drugs in the Pipeline
The FDA has accepted and granted Priority Review for a supplemental New Drug Application (sNDA) for Xalkori (crizotinib; Pfizer).
Drugs in the Pipeline
Synta announced results from its Phase 2 study of ganetespib (STA-9090) for the treatment of NSCLC.
